<a href="https://laohu8.com/S/PGEN">Precigen</a> Inc. Signs Three-Year Commercial Supply Agreement with <a href="https://laohu8.com/S/CTLT">Catalent</a> Maryland for PAPIZEMOS Production
Precigen Inc. has entered into a Commercial Supply Agreement with Catalent Maryland, Inc., effective August 13, 2025. Under this agreement, Catalent will provide services such as analytical, development, processing, validation, and product maintenance for PAPIZEMOS, a product developed by Precigen. Precigen has committed to exclusively utilizing Catalent for external, commercial fill and finish manufacturing of all its reported volumes of the product each year within the specified territory. The initial term of the agreement is three years, with automatic one-year extensions unless terminated by either party with appropriate notice. The agreement includes provisions for pricing adjustments, maintenance fees, and termination conditions due to material breaches or other circumstances.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Precigen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950103-25-010408), on August 18, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.